Illumina Inc. said the Chinese government has lifted a ban on the company selling its DNA sequencing machines inside the ...
Despite Challenges, a Narrow Moat Still Surrounds Illumina in Sequencing and Grail Remains Promising
Illumina aims to transform human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related consumables to help ...
Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.
Illumina’s revenue was flat for the third quarter as the sequencing giant continues to deal with headwinds from a China sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results